ADVOCATE SHERMAN HOSPITAL — History
CCN 140030 | 3-year financial timeline | COVID resilience: 74/100
🛡️ Public data only — no PHI permitted on this instance.
$356M
Latest Revenue (FY2022)
+8.3%
Revenue CAGR (3yr)
-1.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $304M | $337M | $356M | +5.6% | +8.3% |
| Operating Expenses | $332M | $336M | $361M | +7.5% | +4.3% |
| Operating Margin | -9.5% | 0.4% | -1.4% | -504.4% | +0.0% |
| Net Income | $-29M | $1M | $-5M | -527.0% | +0.0% |
| Licensed Beds | 255 | 255 | 255 | +0.0% | +0.0% |
| Total Patient Days | 53,803 | 53,135 | 54,546 | +2.7% | +0.7% |
| Medicare Day % | 34% | 32% | 32% | +0.6% | -2.4% |
| Medicaid Day % | 7% | 7% | 5% | -26.4% | -13.7% |
COVID Impact & Recovery
Resilience Score: 74/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +17.3% ($304M → $356M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.3%
This Hospital
+7.6%
State Avg
Latest Margin
-1.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $382M | 2.6% |
| FY2024 (proj) | $409M | 6.6% |
| FY2025 (proj) | $435M | 10.6% |